Biznes i finanse

SOPHARMA AD (18/2022) Sales revenues for April 2022

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

„Sopharma” AD (the Company) notifies that for April 2022 the Company recorded an increase in sales of 44% compared to the same month of the previous year, incl. 60% increase in domestic sales and 38% increase in export sales as a result of erratic recovery of activity in major foreign markets.

For the four months since the beginning of the year the revenues from sales of products increase by 34%, incl. 75% increase of sales for the domestic market and 10% increase in export sales.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz


Informacja dystrybuowana przez: pap-mediaroom.pl

Wykorzystujemy pliki cookies.
Polityka Prywatności
Więcej
ROZUMIEM